Research article · 24 Feb 2025
Conference abstractPublished 27 Dec 2018
Mechanisms of the progression from Barretts esophagus to esophageal adenocarcinoma: Role of NADPH oxidase NOX5-S
Rhode Island Hospital and Brown University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Esophageal adenocarcinoma (EA) has increased in incidence over the past several decades and is characterized by a poor prognosis. Gastroesophageal reflux disease (GERD) complicated by Barrett’s esophagus (BE) is a major risk factor for the development of EA. There is a progression from BE to dysplasia and to EA. However, the mechanisms of progression from BE to EA are not fully understood. We found that NOX5-S is present in Barrett’s cells BAR-T and EA cells FLO and OE33 and is overexpressed in FLO cells and EA tissues. NOX5-S mRNA is also increased in Barrett’s mucosa with high-grade dysplasia. Pulsed acid treatment significantly increases NOX5-S expression and H2O2 production in BAR-T and OE33 cells and Barrett’s mucosa. These data suggest that NOX5-S may be a source of overproduction of reactive oxygen species (ROS) in BE and in EA cells. We also found that acid-induced increase in NOX5-S expression may depend on activation of Rho kinase, ERK1/2 MAP kinases, and cAMP response element-binding protein. The acid may also induce production of platelet-activating factor, which activates signal transducer and activator of transcription 5 (STAT5) and then upregulates NOX5-S. In addition, NOX5-S mediates an acid-induced increase in cell proliferation in Barrett’s cells BAR-T and EA cells (OE33 and FLO). NOX5-S-mediated increase in cell proliferation may depend on the activation of COX2 and microsomal prostaglandin E synthase 1 (mPGES1), and downregulation of p16 via promoter methylation. NOX5-S also mediates acid-induced DNA damage. These data suggest that persistent acid reflux present in BE patients may upregulate NOX5-S, increase production of ROS and cell proliferation, and cause DNA damage, thereby contributing to the progression from BE to dysplasia and to EA.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Weibiao Cao”